Literature DB >> 22711944

A reliable Pd-mediated hydrogenolytic deprotection of BOM group of uridine ureido nitrogen.

Bilal A Aleiwi1, Michio Kurosu.   

Abstract

The benzyloxymethyl (BOM) group has been utilized widely in syntheses of a variety of natural and non-natural products. The BOM group is also one of few choices to protect uridine ureido nitrongen. However, hydrogenolytic cleavage of the BOM group of uridine derivatives has been unrealizably performed via heterogeneous conditions using Pd catalysts. One of the undesirable by-products formed by Pd-mediated hydrogenation conditions is the over-reduced product of which the C5-C6 double bond of the uracil moiety was saturated. To date, we have generated a wide range of uridine-containing antibacterial agents, where the BOM group has been utilized in their syntheses. In screening of deprotection conditions of the BOM group of uridine ureido nitrogen under Pd-mediated hydrogenation conditions, we realized that the addition of water to the (i)PrOH-based hydrogenation conditions can suppress the formation of over-reduced uridine derivatives and the addition of HCO(2)H (0.5%) dramatically improve the reaction rate. An optimized hydrogenation condition described here can be applicable to the BOM-deprotections of a wide range of uridine derivatives.

Entities:  

Year:  2012        PMID: 22711944      PMCID: PMC3375701          DOI: 10.1016/j.tetlet.2012.05.035

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  28 in total

1.  Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp.

Authors:  Masayuki Igarashi; Naoko Nakagawa; Norio Doi; Seiko Hattori; Hiroshi Naganawa; Masa Hamada
Journal:  J Antibiot (Tokyo)       Date:  2003-06       Impact factor: 2.649

2.  Polymer-supported (2,6-dichloro- 4-alkoxyphenyl)(2,4-dichlorophenyl)methanol: a new linker for solid-phase organic synthesis.

Authors:  Michio Kurosu; Kallolmay Biswas; Dean C Crick
Journal:  Org Lett       Date:  2007-02-21       Impact factor: 6.005

3.  A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206.

Authors:  Ryo Murakami; Yoko Fujita; Masaaki Kizuka; Tomoka Kagawa; Yasunori Muramatsu; Shunichi Miyakoshi; Toshio Takatsu; Masatoshi Inukai
Journal:  J Antibiot (Tokyo)       Date:  2007-11       Impact factor: 2.649

4.  In vitro antimycobacterial activities of capuramycin analogues.

Authors:  Venkata M Reddy; Leo Einck; Carol A Nacy
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

Review 5.  UGT genomic diversity: beyond gene duplication.

Authors:  Chantal Guillemette; Eric Lévesque; Mario Harvey; Judith Bellemare; Vincent Menard
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

6.  Stereoselective synthesis of uridine-derived nucleosyl amino acids.

Authors:  Anatol P Spork; Daniel Wiegmann; Markus Granitzka; Dietmar Stalke; Christian Ducho
Journal:  J Org Chem       Date:  2011-11-21       Impact factor: 4.354

7.  Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

Authors:  Yasunori Muramatsu; Michiko Miyazawa Ishii; Masatoshi Inukai
Journal:  J Antibiot (Tokyo)       Date:  2003-03       Impact factor: 2.649

8.  Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.

Authors:  Hitoshi Hotoda; Miyuki Furukawa; Makiko Daigo; Kazuhiro Murayama; Masakatsu Kaneko; Yasunori Muramatsu; Michiko Miyazawa Ishii; Shun-ichi Miyakoshi; Toshio Takatsu; Masatoshi Inukai; Masayo Kakuta; Tomomi Abe; Tamako Harasaki; Takashi Fukuoka; Yukio Utsui; Satoshi Ohya
Journal:  Bioorg Med Chem Lett       Date:  2003-09-01       Impact factor: 2.823

9.  Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class.

Authors:  Constantine G Boojamra; Rémy C Lemoine; Johanne Blais; Nicole G Vernier; Karin A Stein; Angela Magon; Suzanne Chamberland; Scott J Hecker; Ving J Lee
Journal:  Bioorg Med Chem Lett       Date:  2003-10-06       Impact factor: 2.823

10.  Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

Authors:  H Yamaguchi; S Sato; S Yoshida; K Takada; M Itoh; H Seto; N Otake
Journal:  J Antibiot (Tokyo)       Date:  1986-08       Impact factor: 2.649

View more
  5 in total

1.  Improved synthesis of capuramycin and its analogues.

Authors:  Yong Wang; Shajila Siricilla; Bilal A Aleiwi; Michio Kurosu
Journal:  Chemistry       Date:  2013-09-06       Impact factor: 5.236

2.  Selective esterifications of primary alcohols in a water-containing solvent.

Authors:  Yong Wang; Bilal A Aleiwi; Qinghui Wang; Michio Kurosu
Journal:  Org Lett       Date:  2012-08-31       Impact factor: 6.005

3.  A Convenient Protecting Group for Uridine Ureido Nitrogen: (4,4'-Bisfluorophenyl)methoxymethyl group.

Authors:  Katsuhiko Mitachi; David Mingle; Michio Kurosu
Journal:  Synthesis (Stuttg)       Date:  2021-03-25       Impact factor: 2.969

4.  Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis.

Authors:  Katsuhiko Mitachi; Bilal A Aleiwi; Christopher M Schneider; Shajila Siricilla; Michio Kurosu
Journal:  J Am Chem Soc       Date:  2016-09-26       Impact factor: 15.419

5.  1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors.

Authors:  Yanlin Jian; Fabian Hulpia; Martijn D P Risseeuw; He Eun Forbes; Guy Caljon; Hélène Munier-Lehmann; Helena I M Boshoff; Serge Van Calenbergh
Journal:  Molecules       Date:  2020-06-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.